Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shuangshi Tonglin capsules
- Development stage
- Phase 4
- Lead developer
- Shaanxi Momentum Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Shuangshi Tonglin capsules is a Traditional Chinese Medicine (TCM) formulation used for the treatment of lower urinary tract irritation-related diseases, including chronic prostatitis, acute cystitis, and acute urethritis. The product is composed of several botanical extracts, such as *Pyrrosia lingua*, *Lygodium japonicum*, and *Phellodendron amurense*, which are traditionally used to clear heat, resolve dampness, and promote urination. It is clinically utilized in China to alleviate symptoms like frequent, urgent, and painful urination. Recent clinical evaluations include Phase 4 observational studies comparing its effectiveness and safety against Western treatments like saw palmetto extract or standard antibiotics.
- Brand names
- Shuangshi Tonglin capsules
- Other names
- Shuangshi Tonglin JiaonangShuang Shi Tong Lin Jiao Nang
02
Targets
AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)ALB (Human serum albumin)AMPK (Adenosine monophosphate–activated protein kinase)EGFR (Epidermal growth factor receptor)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)SIRT1 (NAD-dependent protein deacetylase sirtuin-1)TGFB1 (Transforming growth factor Beta-1 proprotein)VEGFA (Vascular endothelial growth factor A)
Beyond the preview
Go deeper on Shuangshi Tonglin capsules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shuangshi Tonglin capsules.